Loss or inhibition of YTHDF1 disrupted NOTCH1 translation, induced DNA damage, and thus synergized with commonly used chemotherapies in CRC, 5-FU and Oxaliplatin, to potentiate tumor eradication in vivo. This evidence concerns the gene YTHDF1 and neoplasm.